Tech Company Financing Transactions
ExPLoRNA Therapeutics Funding Round
Bill & Melinda Gates Foundation participated in a funding round for ExPLoRNA Therapeutics. The financing was announced on 12/7/2022.
Transaction Overview
Company Name
Announced On
12/7/2022
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Total funding will be used for a 14-month project. The project aims to better understand the benefits of ExPLoRNA's cap analogs, especially in terms of reducing the mRNA dose needed for therapeutic effects in the settings of vaccination and monoclonal antibody production.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Zwirki i Wigury 101 lok. nr. 0.30
Warsaw, 02-089
Poland
Warsaw, 02-089
Poland
Phone
Undisclosed
Website
Email Address
Overview
mRNA technologies open unprecedented opportunities to advance disease treatment and prevention. With passion, ExploRNA Therapeutics develops ground-breaking innovations of mRNA as a therapeutic platform, applies those solutions in unique therapeutic programs, and delivers technology, therapeutic platform and therapies to pharmaceutical partners.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jacek Jemielity
Chief Financial Officer
Mateusz Golab
Chief Scientific Officer
Jakub Golab
Chief Technical Officer
Joanna Kowalska
VP - Bus. Development
Piotr Stepniak
VP - Operations
Michal Popinski
Browse more venture capital transactions:
Prev: 12/7/2022: Sound Agriculture venture capital transaction
Next: 12/7/2022: Elastic Path venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs